Illinois Municipal Retirement Fund Acquires New Position in Ingevity Corporation $NGVT

Illinois Municipal Retirement Fund bought a new position in Ingevity Corporation (NYSE:NGVT) in the first quarter, according to its most recent filing with the SEC. The firm bought 20,564 shares of the company’s stock, valued at approximately $1,465,000.

Several other large investors also recently bought and sold shares of NGVT. AQR Capital Management LLC raised its holdings in shares of Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Ingevity by 5.2% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after buying an additional 1,080 shares during the last quarter. Empowered Funds LLC increased its position in shares of Ingevity by 12.9% in the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after acquiring an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the period. Finally, Jane Street Group LLC increased its position in shares of Ingevity by 306.1% in the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after acquiring an additional 66,995 shares during the period. Hedge funds and other institutional investors own 91.59% of the company’s stock.

Insider Buying and Selling

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $68.49, for a total transaction of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares of the company’s stock, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.88% of the company’s stock.

Ingevity Stock Performance

Shares of NYSE NGVT opened at $74.82 on Wednesday. The company has a 50 day simple moving average of $70.86 and a two-hundred day simple moving average of $70.40. The stock has a market cap of $2.60 billion, a price-to-earnings ratio of -21.08 and a beta of 1.16. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83. Ingevity Corporation has a 12 month low of $39.74 and a 12 month high of $79.29.

Ingevity (NYSE:NGVT) last released its quarterly earnings data on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The firm had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same quarter in the prior year, the business earned $1.01 earnings per share. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, analysts predict that Ingevity Corporation will post 5.05 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have commented on NGVT. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Ingevity in a research report on Friday. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a report on Tuesday, July 7th. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Ingevity presently has a consensus rating of “Hold” and an average price target of $80.00.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.